首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   16363篇
  免费   3156篇
  国内免费   3981篇
化学   13186篇
晶体学   476篇
力学   900篇
综合类   446篇
数学   2048篇
物理学   6444篇
  2024年   48篇
  2023年   252篇
  2022年   567篇
  2021年   555篇
  2020年   641篇
  2019年   674篇
  2018年   617篇
  2017年   701篇
  2016年   719篇
  2015年   888篇
  2014年   1026篇
  2013年   1360篇
  2012年   1416篇
  2011年   1554篇
  2010年   1295篇
  2009年   1298篇
  2008年   1435篇
  2007年   1333篇
  2006年   1131篇
  2005年   1006篇
  2004年   805篇
  2003年   633篇
  2002年   657篇
  2001年   614篇
  2000年   508篇
  1999年   349篇
  1998年   203篇
  1997年   156篇
  1996年   169篇
  1995年   137篇
  1994年   135篇
  1993年   86篇
  1992年   78篇
  1991年   70篇
  1990年   49篇
  1989年   49篇
  1988年   43篇
  1987年   46篇
  1986年   30篇
  1985年   25篇
  1984年   17篇
  1983年   22篇
  1982年   22篇
  1981年   6篇
  1980年   9篇
  1979年   13篇
  1978年   11篇
  1976年   7篇
  1965年   6篇
  1964年   4篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
针对RC梁开裂荷载计算方法尚未统一的现状,首先,结合18根RC梁试验数据对比了已有的6种RC梁开裂弯矩计算公式,发现开裂弯矩理论计算值与试验值的偏差大小和混凝土强度有关;然后,通过提出塑性变形发展程度系数k,推导新的RC梁开裂弯矩计算公式,并进一步基于k值和塑性影响系数计算值γk进行改进;最后,选取12根RC试验梁验证改进公式的准确性,证明改进公式的计算值与试验值吻合更好且偏于安全。  相似文献   
992.
研究公路桥梁在移动车辆荷载作用下的动力响应,建立合理的车辆模型非常重要。为更真实地体现桥梁在车载作用下的动力响应,基于LS-DYNA程序,结合常用重型车辆的结构特性及参数,对车辆的橡胶轮胎、轮胎内气体压力、车轮转动和车辆悬架系统进行模拟,使车辆模型更接近实际车辆。通过车辆轴重和动力特性初步验证车辆有限元模型的有效性;同时,以一座混凝土简支空心板梁桥为算例,验证车轮转动和车桥相互接触力,并将LS-DYNA计算结果与桥梁实测结果进行对比,进一步验证车辆有限元模型的有效性。研究结果表明,基于LS-DYNA建立的三维车辆有限元模型是可行的,可以用于研究车桥相互作用。  相似文献   
993.
构造了简单的体外预应力梁的摩擦单元,摩擦单元位于转向块和体外筋之间的角平分线上,能模拟转向块和体外筋之间的有摩擦或无摩擦滑移。考虑混凝土、钢筋和体外筋应力-应变的非线性关系,采用梁截面弯矩-轴力-曲率的三折线模型,探讨了体外预应力梁的性能。对简支梁和连续梁的不同因素进行计算,包括不同摩擦系数、不同体外筋和钢筋面积、不同偏心距以及对称和非对称荷载形式。计算结果表明,对于简支梁和对称荷载下的连续梁,承载力的摩擦效应可以忽略,最大预应力增量和挠度的摩擦效应不宜忽略,最小预应力增量的摩擦效应明显;对于非对称荷载下的连续梁,承载力、最大和最小预应力增量以及挠度的摩擦效应不可忽略。  相似文献   
994.
This paper analyzes the dynamic magnetoelectroelastic behavior induced by a penny- shaped crack in a magnetoelectroelastic layer.The crack surfaces are subjected to only radial shear impact loading.The Laplace and Hankel transform techniques are employed to reduce the prob- lem to solving a Fredholm integral equation.The dynamic stress intensity factor is obtained and numerically calculated for different layer heights.And the corresponding static solution is given by simple analysis.It is seen that the dynamic stress intensity factor for cracks in a magnetoelec- troelastic layer has the same expression as that in a purely elastic material.And the influences of layer height on both the dynamic and static stress intensity factors are insignificant as h/a>2.  相似文献   
995.
Let A be an infinite dimensional stably finite unital simple separable C*-algebra.Let B■A be a stably(centrally)large subalgebra in A such that B is m-almost divisible(m-almost divisible,weakly(m,n)-divisible).Then A is 2(m+1)-almost divisible(weakly m-almost divisible,secondly weakly(m,n)-divisible).  相似文献   
996.
Photosensitizers that can target and accumulate in mitochondria are expected to achieve good therapeutic effects in photodynamic therapy,as mitochondria are the energy generation factory in cells.Herein,we designed and synthesized a novel mitochondrion-targeting photosensitizer TPC-Py with aggregation-induced emission characteristics for image-guided photodynamic therapy.TPC-Py possessed an efficient production of 1O2,with a quantum yield of 11.65%,upon mild white light irradiation(6 mW/cm2).TPC-Py exhibited good biocompatibility under dark condition,but showed remarkable cytotoxicity towards human cervical carcinoma(HeLa)cells with a half maximal inhibitory concentration(IC50)of 3.2μmol/L when exposed to white light irradiation(14.4 J/cm2).In addition,the Stokes shift of TPC-Py was as high as 150 nm,so that it could prevent self-absorption and increase the signal-to-noise ratio of fluorescence imaging.The excellent performance of TPC-Py makes it a promising candidate in imaging-guided clinical PDT for cancer in the near future.  相似文献   
997.
Doxorubicin (DXB) is one of the most commonly used anticancer agents for treating solid and hematological malignancies; however, DXB-induced cardiorenal toxicity presents a limiting factor to its clinical usefulness in cancer patients. Costunolide (COST) is a naturally occurring sesquiterpene lactone with excellent anti-inflammatory, antioxidant and antiapoptotic properties. This study evaluated the effect of COST on DXB-induced cardiorenal toxicity in rats. Rats were orally treated with COST for 4 weeks and received weekly 5 mg/kg doses of DXB for three weeks. Cardiorenal biochemical biomarkers, lipid profile, oxidative stress, inflammatory cytokines, histological and immunohistochemical analyses were evaluated. DXB-treated rats displayed significantly increased levels of lipid profiles, markers of cardiorenal dysfunction (aspartate aminotransferase, creatine kinase, lactate dehydrogenase, troponin T, blood urea nitrogen, uric acid and creatinine). In addition, DXB markedly upregulated cardiorenal malondialdehyde, tumor necrosis factor-α, interleukin-1β, interleukin-6 levels and decreased glutathione, superoxide dismutase and catalase activities. COST treatment significantly attenuated the aforementioned alterations induced by DXB. Furthermore, histopathological and immunohistochemical analyses revealed that COST ameliorated the histopathological features and reduced p53 and myeloperoxidase expression in the treated rats. These results suggest that COST exhibits cardiorenal protective effects against DXB-induced injury presumably via suppression of oxidative stress, inflammation and apoptosis.  相似文献   
998.
The first example of Rh-catalyzed kinetic resolution of 1,3-disubstituted allene-1,3-dienes involving intramolecular[4+2]-cycloaddition has been developed.Follo...  相似文献   
999.
The ring-polymer molecular dynamics (RPMD) was used to calculate the thermal rate coefficients and kinetic isotope effects of the heavy-light-heavy abstract reaction Cl+XCl\begin{document}$ \rightarrow $\end{document}XCl+Cl (X = H, D, Mu). For the Cl+HCl reaction, the excellent agreement between the RPMD and experimental values provides a strong proof for the accuracy of the RPMD theory. And the RPMD results are also consistent with results from other theoretical methods including improved-canonical-variational-theory and quantum dynamics. The most novel finding is that there is a double peak in Cl+MuCl reaction near the transition state, leaving a free energy well. It comes from the mode softening of the reaction system at the peak of the potential energy surface. Such an explicit free energy well suggests strongly there is an observable resonance. And for the Cl+DCl reaction, the RPMD rate coefficient again gives very accurate results compared with experimental values. The only exception is at the temperature of 312.5 K, results from RPMD and all other theoretical methods are close to each other but slightly lower than the experimental value, which indicates experimental or potential energy surface deficiency.  相似文献   
1000.
As one of the key phosphatidylinositol 3-kinase-related kinases (PIKKs) family members, ataxia telangiectasia and RAD3-related protein kinase (ATR) is crucial in maintaining mammalian cell genomic integrity in DNA damage response (DDR) and repair pathways. Dysregulation of ATR has been found across different cancer types. In recent years, the inhibition of ATR has been proven to be effective in cancer therapy in preclinical and clinical studies. Importantly, tumor-specific alterations such as ATM loss and Cyclin E1 (CCNE1) amplification are more sensitive to ATR inhibition and are being exploited in synthetic lethality (SL) strategy. Besides SL, synergistic anticancer effects involving ATRi have been reported in an increasing number in recent years. This review focuses on the recent advances in different forms of synergistic antitumor effects, summarizes the pharmacological benefits and ongoing clinical trials behind the biological mechanism, and provides perspectives for future challenges and opportunities. The hope is to draw awareness to the community that targeting ATR should have great potential in developing effective anticancer medicines.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号